220 related articles for article (PubMed ID: 32111001)
21. Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.
Zheng J; Yang Y; Cui M; Shu ZJ; Han LL; Liu ZQ; Wood C; Zhang T; Zeng Y
Virol Sin; 2017 Oct; 32(5):396-403. PubMed ID: 29116591
[TBL] [Abstract][Full Text] [Related]
22. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
[TBL] [Abstract][Full Text] [Related]
23. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
24. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.
Olsen SJ; Chang Y; Moore PS; Biggar RJ; Melbye M
AIDS; 1998 Oct; 12(14):1921-5. PubMed ID: 9792393
[TBL] [Abstract][Full Text] [Related]
25. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection
Muniraju M; Mutsvunguma LZ; Reidel IG; Escalante GM; Cua S; Musonda W; Calero-Landa J; Farelo MA; Rodriguez E; Li Z; Ogembo JG
J Virol; 2024 Jun; 98(6):e0057624. PubMed ID: 38767375
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
28. Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals.
Robey RC; Mletzko S; Bower M; Meys R; Boffito M; Nelson M; Bunker CB; Gotch FM
Viral Immunol; 2011 Jun; 24(3):211-20. PubMed ID: 21668362
[TBL] [Abstract][Full Text] [Related]
29. Systematic analysis of Kaposi's sarcoma (KS)-associated herpesvirus genomes from a KS case-control study in Cameroon: Evidence of dual infections but no association between viral sequence variation and KS risk.
Marshall VA; Fisher NC; Goodman CA; Cornejo Castro EM; Liu I; Khanal S; Holdridge BM; Thorpe AL; Labo N; Stolka KB; Hemingway-Foday JJ; Abassora M; N'Dom P; Smith JS; Sallah N; Palser AL; Kellam P; Keele BF; Whitby D
Int J Cancer; 2022 Oct; 151(7):1127-1141. PubMed ID: 35608873
[TBL] [Abstract][Full Text] [Related]
30. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
Uppal T; Meyer D; Agarwal A; Verma SC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
[TBL] [Abstract][Full Text] [Related]
31. Biology of Kaposi's sarcoma-associated herpesvirus.
Bryan BA; Dyson OF; McCubrey JA; Akula SM
Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
[TBL] [Abstract][Full Text] [Related]
32. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
[TBL] [Abstract][Full Text] [Related]
34. Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.
Muniraju M; Mutsvunguma LZ; Foley J; Escalante GM; Rodriguez E; Nabiee R; Totonchy J; Mulama DH; Nyagol J; Wussow F; Barasa AK; Brehm M; Ogembo JG
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142670
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China.
Wang H; Liu J; Dilimulati ; Li L; Ren Z; Wen H; Wang X
Virol J; 2011 Dec; 8():539. PubMed ID: 22168313
[TBL] [Abstract][Full Text] [Related]
36. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.
Corbellino M; Poirel L; Bestetti G; Pizzuto M; Aubin JT; Capra M; Bifulco C; Berti E; Agut H; Rizzardini G; Galli M; Parravicini C
AIDS Res Hum Retroviruses; 1996 May; 12(8):651-7. PubMed ID: 8744575
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's Sarcoma-Associated Herpesvirus ORF68 Is a DNA Binding Protein Required for Viral Genome Cleavage and Packaging.
Gardner MR; Glaunsinger BA
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875246
[TBL] [Abstract][Full Text] [Related]
38. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function.
Yang WS; Lin TY; Chang L; Yeh WW; Huang SC; Chen TY; Hsieh YT; Chen ST; Li WC; Pan CC; Campbell M; Yen CH; Chen YA; Chang PC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723026
[TBL] [Abstract][Full Text] [Related]
40. Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.
Chatterjee D; Chandran B; Berger EA
MAbs; 2012; 4(2):233-42. PubMed ID: 22377676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
